Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ANAGRELIDE MEVON CAPSULES 0.5 MG - HSA Drug Approval Details

Approvals/HSA/ANAGRELIDE MEVON CAPSULES 0.5 MG

Approved

THERAPEUTIC

ANAGRELIDE MEVON CAPSULES 0.5 MG

Titan Laboratories Pvt. Ltd.🇸🇬 Health Sciences Authority

Approval Date: Oct 17, 2024
Approval ID: 1168e4245bd4aaf8
Company: Titan Laboratories Pvt. Ltd.
Type: Therapeutic

Approval Details

Approval Id: 1168e4245bd4aaf8
Drug Name: ANAGRELIDE MEVON CAPSULES 0.5 MG
Product Name: ANAGRELIDE MEVON CAPSULES 0.5 MG
Approval Number: SIN17118P
Approval Date: 2024-10-17
Registrant: NOVEM PHARMA PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: L01XX35
Pharma Manufacturer Name: NOVEM PHARMA PRIVATE LIMITED
Company Detail Path: /organization/66db3ea384434852/novem-pharma-private-limited

Active Ingredients

Anagrelide HCl eqv Anagrelide

0.5 mg

Anagrelide HCl eqv Anagrelide

0.5 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 17, 2024

Approval ID

1168e4245bd4aaf8

Type

Therapeutic

Back to HSA Approvals